A Global Leading Company in Antibody Therapeutics

Platform technologies and pipelines Ymax-CEPT

Receptor library

Y-Biologics has secured receptor library, Ymax-CEPT, which is able to discover new disease-relatedtarget. Ymax-CEPT is created by cloningextracellular portion of plasma membrane protein, which is important for the function by interacting with ligand or binding partners, in fusion with the human Fc fragment. As Ymax-CEPT features similar structure and post-translational modification to its native receptor protein by using mammalian expression system,it is an effective platform technologyfor the discovery of new target related to various disease.

Assays for target discovery

  • 1

    Selection of direct interacting partner by ELISA

  • 2

    Selection of functional interacting partner by cell-based assay